title: FDA statement regarding the use of adeno-associated virus reference standard materials.
authors: Office of Cellular , Tissue, and Gene Therapies, U.S. FDA, Silver Spring, MD 20993.
authors: Denise K
authors: DK
authors: Gavin
mesh_terms: D000229:Dependovirus / Q000235:genetics*; D015316:Genetic Therapy / Q000331:legislation & jurisprudence / Q000592:standards*; D005822:Genetic Vectors / Q000009:adverse effects / Q000592:standards*; D012015:Reference Standards; D014481:United States; D014486:United States Food and Drug Administration